NM_020661.4:c.169G>A
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_020661.4(AICDA):c.169G>A(p.Val57Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V57A) has been classified as Uncertain significance.
Frequency
Consequence
NM_020661.4 missense
Scores
Clinical Significance
Conservation
Publications
- hyper-IgM syndrome type 2Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AICDA | NM_020661.4 | c.169G>A | p.Val57Met | missense_variant | Exon 3 of 5 | ENST00000229335.11 | NP_065712.1 | |
| AICDA | NM_001330343.2 | c.169G>A | p.Val57Met | missense_variant | Exon 3 of 5 | NP_001317272.1 | ||
| AICDA | NM_001410970.1 | c.169G>A | p.Val57Met | missense_variant | Exon 3 of 4 | NP_001397899.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727246 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hyper-IgM syndrome type 2 Pathogenic:2
Variant summary: AICDA c.169G>A (p.Val57Met) results in a conservative amino acid change located in the APOBEC-like, N-terminal domain (IPR013158) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 248508 control chromosomes. c.169G>A has been observed in multiple homozygous individuals affected with Hyper IgM Syndrome Type 2 (Al-Mousa2016, Al-Herz_2018). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30697212, 26915675). ClinVar contains an entry for this variant (Variation ID: 191031). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at